Cellular uptake of the tat protein from human immunodeficiency virus
暂无分享,去创建一个
[1] J. Northrop,et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Sodroski,et al. Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[3] G. Pavlakis,et al. Expression and characterization of the trans-activator of HTLV-III/LAV virus. , 1986, Science.
[4] R. Gaynor,et al. Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP‐1 and UBP‐1. , 1988, The EMBO journal.
[5] J. Sodroski,et al. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. , 1985, Science.
[6] Bryan R. Cullen,et al. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism , 1986, Cell.
[7] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[8] M. Gonda,et al. The trans-activator gene of HTLV-III is essential for virus replication , 1986, Nature.
[9] B. Howard,et al. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.
[10] F. Studier,et al. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. , 1986, Journal of molecular biology.
[11] T. Quinn,et al. The association between malaria, blood transfusions, and HIV seropositivity in a pediatric population in Kinshasa, Zaire. , 1988, JAMA.
[12] J. Sodroski,et al. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. , 1985, Science.
[13] C. Pabo,et al. Dimerization of the tat protein from human immunodeficiency virus: a cysteine-rich peptide mimics the normal metal-linked dimer interface. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Ho,et al. Reactivity of E. coli-derived trans-activating protein of human T lymphotropic virus type III with sera from patients with acquired immune deficiency syndrome. , 1986, Journal of immunology.
[15] C. Debouck,et al. Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. Mulligan,et al. Expression of the mouse dihydrofolate reductase complementary deoxyribonucleic acid in simian virus 40 vectors , 1981, Molecular and cellular biology.
[17] S W Lin,et al. Vectors for selective expression of cloned DNAs by T7 RNA polymerase. , 1987, Gene.
[18] J. Sodroski,et al. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat , 1985, Cell.
[19] D. Bredt,et al. Tat protein from human immunodeficiency virus forms a metal-linked dimer. , 1988, Science.
[20] J. Sodroski,et al. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication , 1986, Cell.
[21] I Mellman,et al. Acidification of the endocytic and exocytic pathways. , 1986, Annual review of biochemistry.
[22] S. Arya,et al. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). , 1985, Science.
[23] M. Robert-Guroff,et al. Spectrum of natural antibodies against five HTLV-III antigens in infected individuals: correlation of antibody prevalence with clinical status. , 1987, Blood.
[24] F. Mcmahon. The Pharmacological Basis of Therapeutics , 1986 .
[25] S. Arya,et al. Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[26] B. Cullen,et al. Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[27] K. Struhl,et al. Current Protocols in Molecular Biology (New York: Greene Publishing Associates and Wiley-Interscience). Host-Range Shuttle System for Gene Insertion into the Chromosomes of Gram-negative Bacteria. , 1988 .
[28] J. Sodroski,et al. Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus , 1987, Nature.
[29] D. Taylor,et al. A method for incorporating macromolecules into adherent cells , 1984, The Journal of cell biology.
[30] G. Pavlakis,et al. A quantitative bioassay for HIV-1 based on trans-activation. , 1988, Science.
[31] B. Cullen,et al. Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat , 1988, Journal of virology.
[32] D. Capon,et al. A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator , 1988, Molecular and cellular biology.
[33] R. Gaynor,et al. Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. , 1987, The EMBO journal.
[34] D. Capon,et al. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein , 1987, Cell.